XML 73 R27.htm IDEA: XBRL DOCUMENT

Equity Method Investments (Tables)

3 Months Ended

Mar. 31, 2025

Equity Method Investments and Joint Ventures [Abstract]

The following table summarizes our equity method investments, which were included in other assets on the condensed consolidated balance sheets (in millions):


Investee	Ownership Percentage	March 31, 2025		December 31, 2024
EMEA 1 Joint Venture	20%	$	133	$	131
VIE Joint Ventures (1)	20%	432		374
Other	Various	13		14
Total		$	578	$	519

(1)Includes investments in the following xScale joint ventures in each of our three regions: "Asia-Pacific 1 Joint Venture", "Asia-Pacific 2 Joint Venture", "Asia-Pacific 3 Joint Venture", "EMEA 2 Joint Venture", "AMER 1 Joint Venture" and "AMER 2 Joint Venture". These investments share a similar purpose, design and nature of assets.

Schedule of The Maximum Exposure Losses of VIE Joint Ventures

The following table summarizes our maximum exposure to loss related to the VIE Joint Ventures as of March 31, 2025 (in millions):


	VIE Joint Ventures
Equity Investment	$	432
Outstanding Accounts Receivable	83
Other Receivables	40
Contract Assets	109
Loan Commitment (1)	392
Future Equity Contribution Commitments (2)	112
Maximum Future Payments under Debt Guarantees (3)	268
Total	$	1,436

(1)Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement with the AMER 2 Joint Venture, as a lender, further discussed below.

(2)The joint ventures' partners are required to make additional equity contributions proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments on their outstanding debt.

(3)In connection with our 20% equity investment in the EMEA 2 Joint Venture, we provided the lenders with our guarantees covering 20% of all payments of principal and interest due under the EMEA 2 Joint Venture's credit facility agreements. A portion of the guarantees relates to our AMER 1 Joint Venture. Refer to Note 10.

The following table presents the assets and liabilities of the Indonesian VIE, which were included in other assets and other liabilities on the condensed consolidated balance sheets (in millions):


Balance Sheet	March 31, 2025		December 31, 2024
Cash and cash equivalents	$	11	$	16
Property, plant and equipment, net	55		25
Other	8		5
Total assets	$	74	$	46
Total liabilities	$	35	$	5

Schedule of Other Related Party Transactions

The following table presents the income and expenses from these arrangements with the Joint Ventures in our condensed consolidated statements of operations (in millions):


		Three Months Ended March 31,
Related Party	Nature of Transaction		2025		2024
EMEA 1 Joint Venture	Income		$	6	$	6
EMEA 1 Joint Venture	Expenses (1)		4		4
VIE Joint Ventures	Income (2)		61		38
VIE Joint Ventures	Expenses (3)		2		1

(1)Primarily consists of rent expenses for a sub-lease agreement with the EMEA 1 Joint Venture for a London data center with a remaining lease term of approximately 15-years as of March 31, 2025.

(2)Primarily consists of revenues related to service arrangements as described above and also includes interest income earned on the AMER 2 Loan during the three months ended March 31, 2025 of $7 million.

(3)Primarily consists of rent expenses for lease arrangements with the VIE Joint Ventures.

The following table presents the assets and liabilities from related party transactions with the Joint Ventures in our condensed consolidated balance sheets (in millions):


	EMEA 1 Joint Venture				VIE Joint Ventures
Balance Sheet	March 31, 2025		December 31, 2024		March 31, 2025		December 31, 2024
Accounts receivable, net	$	30	$	4	$	83	$	50
Other current assets (1)	19		19		139		128
Property, plant and equipment, net (2)	146		145		73		74
Operating lease right-of-use assets	2		2		29		2
Other assets (3)	—		—		276		302
Other current liabilities	6		5		8		10
Finance lease liabilities	169		164		78		78
Operating lease liabilities	2		2		27		2
Other liabilities (4)	49		48		11		11

(1)The balance primarily relates to contract assets and other receivables.

(2)The balance relates to finance lease right-of-use assets.

(3)The balance primarily relates to the AMER 2 Loan receivable.

(4)The balance primarily relates to the obligation to pay for future construction for certain sites sold as a part of the EMEA 1 Joint Venture transaction.

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details